Headwater Science Studio suite powers every stage of the evidence lifecycle from interactive scientific analysis to causal and risk modeling, continuously updating disease libraries and governance infrastructure.

Built for researchers who need rigorous, reproducible, audit-ready results 

causalStudio™

An integrated environment for designing, executing, and communicating observational research — built around the methodological standards that regulators, HTA bodies, and reviewers now expect.

The platform operationalizes advanced causal inference methods — including IPTW, time-varying treatments, informative censoring, and competing risks — so that methodological rigor becomes part of the workflow, not an afterthought. It supports pre-specification, reproducibility, and analytic transparency from study design through final output. Deployable across data environments, with no dependency on a single data source.

causalPHR™

Interactive reporting and visualization — built specifically for the life sciences research context.

causalPHR™ connects directly with causalRisk™ to turn analytical outputs into interactive, shareable reports. Filtering, stratification, peer review workflows, and visualizations designed for the way observational research is actually communicated — to colleagues, sponsors, and reviewers alike.

Cumulative risk plotsForest plots & Sankey diagramsSubgroup & stratification filtersCollaborative peer review workflowFull methods documentation

Use Cases: 

The platform has been applied across a range of study types — from negative control outcome assessments and trial emulations to external control arm construction and treatment adherence analyses.

Causal inference

• Negative control outcome studies to assess treatment group comparability

Trial emulation

• Emulating randomized trials for newly diagnosed immune thrombocytopenia

External control arms

• Approaches to selecting time zero with multiple potential entry points

Treatment adherence

• Estimating the effect of preventable treatment discontinuation on outcomes

Methods development

• Using instrumental variables to address bias from unobserved confounders

Descriptive epidemiology

• Lipid testing trends before and after myocardial infarction hospitalization

Why Headwater Science

Built by methodologists

• Developed by epidemiologists and statisticians

Regulatory track record

• Used and validated in support of regulatory decision-making — not just research-grade software.

Data agnostic

• Deploys across data sources and environments. 

Defensible by design

• Pre-specification, versioning, and audit-readiness are built into the workflow — not added at the end.

We design studies across the study types pharma teams need most, applying the same rigorous causal inference framework regardless of question type or data source.

Comparative effectiveness & safety

• Head-to-head treatment comparisons in real-world populations, designed to isolate treatment effects from the confounding inherent in observational data.

External control arms

• Historically controlled comparator groups constructed from realworld data to support single arm trials,  with rigorous attention to time zero, eligibility alignment, and bias protection.

Trial emulation

• Trial emulation frameworks that bring the design discipline of randomized trials to observational analyses, supporting label expansion and regulatory submissions.

Negative control outcome studies

• Precomparative assessments that evaluate whether treatment groups are sufficiently comparable before a study is run,  catching bias problems early, not after results are in.

Treatment patterns & adherence

• How patients actually use treatments in practice: initiation, switching, discontinuation, and the downstream outcome consequences of each.

Healthcare utilization & costs

• Resource use, expenditure, and burden of illness analyses that inform payer and HTA submissions as well as internal commercial decision-making.

Descriptive epidemiology

• Disease natural history, incidence, prevalence, and population characterization studies, often the foundation for every study type above.

Subpopulation & high-risk analyses

• Targeted investigations of specific patient segments where standard population-level findings don't apply and where the clinical or regulatory stakes are highest.